Hepatoblastoma

Revision as of 02:07, 14 January 2009 by Zorkun (talk | contribs)
Jump to navigation Jump to search
Hepatoblastoma
ICD-10 C22.0
ICD-O: 8970/3
DiseasesDB 5799
eMedicine ped/982  radio/331
MeSH D018197

WikiDoc Resources for Hepatoblastoma

Articles

Most recent articles on Hepatoblastoma

Most cited articles on Hepatoblastoma

Review articles on Hepatoblastoma

Articles on Hepatoblastoma in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Hepatoblastoma

Images of Hepatoblastoma

Photos of Hepatoblastoma

Podcasts & MP3s on Hepatoblastoma

Videos on Hepatoblastoma

Evidence Based Medicine

Cochrane Collaboration on Hepatoblastoma

Bandolier on Hepatoblastoma

TRIP on Hepatoblastoma

Clinical Trials

Ongoing Trials on Hepatoblastoma at Clinical Trials.gov

Trial results on Hepatoblastoma

Clinical Trials on Hepatoblastoma at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Hepatoblastoma

NICE Guidance on Hepatoblastoma

NHS PRODIGY Guidance

FDA on Hepatoblastoma

CDC on Hepatoblastoma

Books

Books on Hepatoblastoma

News

Hepatoblastoma in the news

Be alerted to news on Hepatoblastoma

News trends on Hepatoblastoma

Commentary

Blogs on Hepatoblastoma

Definitions

Definitions of Hepatoblastoma

Patient Resources / Community

Patient resources on Hepatoblastoma

Discussion groups on Hepatoblastoma

Patient Handouts on Hepatoblastoma

Directions to Hospitals Treating Hepatoblastoma

Risk calculators and risk factors for Hepatoblastoma

Healthcare Provider Resources

Symptoms of Hepatoblastoma

Causes & Risk Factors for Hepatoblastoma

Diagnostic studies for Hepatoblastoma

Treatment of Hepatoblastoma

Continuing Medical Education (CME)

CME Programs on Hepatoblastoma

International

Hepatoblastoma en Espanol

Hepatoblastoma en Francais

Business

Hepatoblastoma in the Marketplace

Patents on Hepatoblastoma

Experimental / Informatics

List of terms related to Hepatoblastoma

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Hepatoblastoma is an uncommon malignant liver neoplasm occurring in infants and children and composed of tissue resembling fetal or mature liver cells or bile ducts. They usually present with an abdominal mass. Alpha-fetoprotein (AFP) commonly is elevated, but when AFP is not elevated at diagnosis the prognosis is poor.[1]

Signs and Symptoms

Possible signs of childhood liver cancer include a lump or pain in the abdomen.

Symptoms are more common after the tumor becomes large. Other conditions can cause the same symptoms.

  • A painless lump in the abdomen.
  • Swelling or pain in the abdomen.
  • Weight loss for no known reason.
  • Loss of appetite.
  • Early puberty in boys.
  • Nausea and vomiting.

Diagnosis of Childhood Liver Cancer

The following tests and procedures may be used:

  • Physical exam and history: An exam of the body to check general signs of health, including checking for signs of disease, such as lumps or anything else that seems unusual. A history of the patient's health habits and past illnesses and treatments will also be taken.
  • Serum tumor marker test: A procedure in which a blood sample is checked to measure the amounts of certain substances released into the blood by organs, tissues, or tumor cells in the body. Certain substances are linked to specific types of cancer when found in increased levels in the blood. These are called tumor markers. The blood of children who have liver cancer may have increased amounts of a protein called alpha-fetoprotein (AFP) or a hormone called beta-human chorionic gonadotropin (β-hCG). Other cancers and certain noncancerous conditions, including cirrhosis and hepatitis, may also increase AFP levels.
  • Complete blood count (CBC): A procedure in which a sample of blood is drawn and checked for the following:
  • The number of red blood cells, white blood cells, and platelets.
  • The amount of hemoglobin (the protein that carries oxygen) in the red blood cells.
  • The portion of the blood sample made up of red blood cells.
  • Liver function tests: A procedure in which a blood sample is checked to measure the amounts of certain substances released into the blood by the liver. A higher than normal amount of a substance can be a sign of liver cancer.
  • Abdominal x-ray: An x-ray of the organs in the abdomen. An x-ray is a type of energy beam that can go through the body onto film, making a picture of areas inside the body.
  • Ultrasound exam: A procedure in which high-energy sound waves (ultrasound) are bounced off internal tissues or organs and make echoes. The echoes form a picture of body tissues called a sonogram. The picture can be printed to be looked at later.
  • CT scan (CAT scan): A procedure that makes a series of detailed pictures of areas inside the body, taken from different angles. The pictures are made by a computer linked to an x-ray machine. A dye may be injected into a vein or swallowed to help the organs or tissues show up more clearly. This procedure is also called computed tomography, computerized tomography, or computerized axial tomography. In childhood liver cancer, a CT scan of the chest and abdomen is usually done.
  • MRI (magnetic resonance imaging): A procedure that uses a magnet, radio waves, and a computer to make a series of detailed pictures of areas inside the body. This procedure is also called nuclear magnetic resonance imaging (NMRI).
  • Biopsy: The removal of cells or tissues so they can be viewed under a microscope to check for signs of cancer. The sample may be taken during surgery to remove or view the tumor. A pathologist views the sample under a microscope to determine the type of liver cancer.

Treatment

Surgical resection, adjuvant chemotherapy prior to resection, and liver transplantation have been used to treat these neoplasms.

Factors that Affect Prognosis (chance of recovery) and Treatment Options

The prognosis (chance of recovery) and treatment options depend on the following:

  • The stage of the cancer (the size of the tumor, whether it affects part or all of the liver, and whether it has spread to other places in the body, such as the lungs).
  • Whether the cancer can be removed completely by surgery.
  • The type of liver cancer (hepatoblastoma or hepatocellular).
  • Whether the cancer has just been diagnosed or has recurred.

Prognosis may also depend on:

  • Certain features of the cancer cell (how it looks under a microscope).
  • Whether the AFP blood levels go down after chemotherapy begins.

References

  1. De Ioris M, Brugieres L, Zimmermann A, Keeling J, Brock P, Maibach R, Pritchard J, Shafford L, Zsiros J, Czaudzerna P, Perilongo G (2007). "Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: The SIOPEL group experience". Eur J Cancer. 44: 545. doi:10.1016/j.ejca.2007.11.022. PMID 18166449.

External links

Template:SIB
de:Hepatoblastom


Template:WikiDoc Sources